ATF3 and Hypoglycemia: In order to investigate the mechanism underlying the differential effects of VCD during hypoglycemia (inhibition of GRP78) vs. hypoxia (no inhibition of GRP78), we wanted to add VCD to cells under dual treatment with hypoglycemia plus hypoxia, and then investigate the stress markers GRP78, CHOP, and ATF3.